Bexion Pharmaceuticals gets FCA approval for a clinical trial of its first-in-class treatment of cancer
Bexion Pharmaceuticals, LLC (‘Bexion”) announced today that the U.S. Food and Drug Administration (FDA) cleared Bexion’s application to initiate a…